Abstract: Trichoderma spp. strains with high capacity for fungus biological control in wide ranges of temperature and pH are described, such strains being compatible with each other. Likewise, a process of selection of such strains through molecular markers is described. The described process reduce the number of necessary experiments to determine if a Trichoderma strain, not previously described, can display a biological activity more acceptable than those well known.

Abstract: In the present invention, a recombination of gene groups of nemadectin aglycon biosynthesis is performed for obtaining C-13 hydroxylnemadectin, to which sugar groups can be attached, and a production strain which produces C-13 hydroxylnemadectin is produced. Further, C-13 glycosylnemadectin producing strain is prepared by introducing aveBI-BVIII genes involving glycosidation of avermectin and biosynthesis of oleandrose. As described, C-13 hydroxylnemadectin and C-13 glycosidated nemadectin can be obtained effectively by using the producing strain prepared by means of the molecular genetic technology, and improvement in the biological activity thereof can be expected.

Abstract: Brevibacillus choshinensis is characterized in that its extracellular proteolytic activity is extremely low and its protein secretion productivity is excellent, but it is desired that not only the extracellular proteolytic activity of the strain is further reduced but also the intracellular proteolytic activity thereof is further reduced. When Brevibacillus choshinensis is used as a host for the production of protein pharmaceuticals and the like, it is also desired that it does not form spores and is readily sterilized. The above problems have been solved by inactivating the sporulation-associated gene thereof and by cloning and inactivating the extracellular and intracellular protease genes thereof.

Abstract: The present invention relates to methods for complexing a protein in a dispersed medium. Also disclosed are associated proteins produced by the methods of complexing of the present invention. Pharmaceutically effective stabilized protein dosages are also disclosed. The present invention also relates to a method for associating AHF protein in a dispersed medium.

Abstract: The present invention is related to an isolated chemolithotrophic bacterial strain belonging to the specie Acidithiobacillus ferrooxidans, named “Wenelen” and deposited at the Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH—DSMZ under classification number DSM 16786, the use of said bacteria for leaching ores or concentrates containing of metallic sulfide species and leaching processes based on the use of said bacteria or mixtures that contain said bacteria. This Wenelen DSM 16786 strain has an increased oxidizing activity, especially regarding chalcopyrite, when compared to known bacteria. Due to the former feature, this bacteria strain show great interest for biomining applications and it is presently being subjected to annotation processes after sequencing.

Abstract: A process for producing lipids containing arachidonic acid comprising culturing a microorganism in which ?3 desaturase activity has been decreased or is lacking at a temperature lower than the optimum growth temperature from the start of culturing or after culturing at the optimum growth temperature, said microorganism being obtained by the mutation treatment of a microorganism capable of producing arachidonic acid and belonging to the genus Mortierella and the like; and then recovering lipids containing arachidonic acid from the culture.

Abstract: A process for producing herbicides from a fungus Alternaria alteranata f.sp. lantanae deposited as a pure culture as MTCC 5432 and ITCC-4896, comprising culturing the fungus in a liquid broth; subjecting the broth to the step of filtration to separate the broth containing phytotoxins from mycelium; extracting the phytotoxins from said broth to obtain the phytotoxins; and subjecting the phytotoxins to chemical characterization.

Abstract: The present invention relates to a combination of a Neotyphodium species endophyte or endophyte culture in a symbiotic association with a host grass which association does not cause symptoms of toxicosis in animals through exclusion of ergovaline but, due to the inclusion of alkaloids including agroclavine, setoclavine or isosetoclavine, retains the ability to resist abiotic stresses and protect the grass from pests.

Abstract: The invention provides a novel microorganism producing pravastatin sodium, as well as the method for producing pravastatin sodium by using this microorganism. Micropolyspora roseoalba CGMCC 0624 of the invention is highly tolerant to mevastatin sodium, and has a high transformation rate of mevastatin sodium, and can produce pravastatin sodium with a high efficiency and low cost.

Abstract: The present invention relates to a process for preparing (2R,3S)-1-halo-2-hydroxy-3-(protected)amino-4-substituted butane comprising contacting a mutagenized Rhodococcus erythropolis having ATCC deposit no. PTA-6648 with (3S)-1-halo-2-oxo-3-(protected)amino-4-substituted butane substrate. The present invention also relates to a process comprising mixing (2R,3S)-1-halo-2-hydroxy-3-(protected)amino-4-substituted butane with at least one base in the presence of at least one solvent to produce a reaction mixture containing (2R,3S)-1,2-epoxy-3-(protected)amino-4-substituted butane. The present invention further relates to a process comprising crystallizing the (2R,3S)-1,2-epoxy-3-(protected)amino-4-substituted butane out of the reaction mixture by concurrently adding water and the reaction mixture together. The present invention is also directed to a mutagenized Rhodococcus erythropolis having ATCC deposit no. PTA-6648.

Abstract: Bacillus subtilis var. chungkookjang, accession no. KCTC 0697BP, a salt-resistant B. subtilis variant isolated from “chungkookjang,” a traditional Korean fermented soy bean paste. This B. subtilis variant produces poly-gamma-glutamic acid (or poly-gamma-glutamate, ?-PGA), an edible, soluble, anionic, and biodegradable high molecular-weight polymer. Bacillus subtilis var. chungkookjang produces ?-PGA with a higher molecular weight than other extracellular ?-PGAs derived from general Bacillus sp. strains. Accordingly, the ?-PGA produced by Bacillus subtilis var. chungkookjang can be utilized for the development of high value-added products, such as cosmetics, absorption agents, and biodegradable plastic materials.

Abstract: The invention relates to a structured composite as a carrier for the tissue engineering and implant material of bones, consisting of a mass of porous calcium phosphate granulates. The granulated material has a grain size of between 0.5 and 10 mm with macropores and micropores, and the macropores have an average diameter of between 50 and 500 ?m and are bound by a biocompatible binding agent.

Abstract: The present inventors discovered that the onset of galactosamine hepatopathy is suppressed by nutritional compositions comprising as essential ingredients: whey protein hydrolysates; lecithin and oils and fats high in oleic acid, which are able to improve the lipid metabolism; and palatinose having an insulin-sparing effect. Furthermore, the whey protein hydrolysate included in the nutritional compositions was found to suppress endotoxin-induced TNF-a and interleukin 6 (IL-6) production in macrophages.

Abstract: A process is described for producing a polymer-coated, granulated, enzyme-containing feedstuff additive, the polymer-coated feedstuff additives obtainable in this manner and pelleted feedstuff compositions which are produced with use of the polymer-coated additives.

Abstract: Invented are non-peptide TPO mimetics. Also invented is a method of treating thrombocytopenia, in a mammal, including a human, in need thereof which comprises administering to such mammal an effective amount of a selected hydroxy-1-azobenzene derivative.

Abstract: Microbial biodegradation can be presented as a preferred technique for plastic disposal from the viewpoint of protection of the natural environment, but a problem exists in that plastics are generally not biodegradable. The present invention provides a microorganism capable of degrading a urethane compound and a method for degrading a urethane compound using the microorganism. More particularly, the present invention aims to provide a microorganism capable of degrading a urethane compound used as a source material for polyurethanes and a method for degrading a polyurethane using the microorganism.

Abstract: Described herein are nitrite-oxidizing bacteria. Particular bacteria of the present invention are tolerant of saltwater environments, saltwater environments, or both. Furthermore, in various embodiments, various bacteria of the present invention are capable of surviving a freezing or freeze-drying process, and may remain viable thereafter. Methods for preventing or alleviating the accumulation of nitrite in aqueous environments are also provided, using the nitrite-oxidizing bacteria of the present invention. Methods for detecting the bacteria of the present invention are also provided. Compositions comprising the nitrite-oxidizing bacteria of the present invention and, inter alia, ammonia-oxidizing bacteria, are also provided.

Abstract: The invention can be summarized as follows. There is provided a method of bleaching chemical pulp comprising the steps of exposing chemical pulp to a chemical bleaching state to produce a partially bleached pulp and treating the partially bleached pulp with a thermophilic, alkalophilic xylanase in an alkaline extraction stage at pH of 8 to 14. The method may be performed in a mill and may form part of a more complex pulp bleaching process. The invention also relates to the use of a thermophilic, alkalophilic xylanase in an alkaline extraction stage of a pulp bleaching process in a mill.

Abstract: A process for preparing lipids which contain docosahexaenoic acid (DHA) and/or docosapentaenoic acid (DPA) is disclosed. The process includes the steps of cultivating in a medium a microorganism which belongs to the genus Ulkenia having the ability to produce DHA and/or DPA and recovering the lipids from the culture. The process may further include the step of separating DHA and/or DPA from the lipids.

Abstract: The present invention discloses a method for the enzyme-mediated, site-specific, in-vivo precipitation of a water soluble molecule in an animal. The enzyme is either unique to tumor cells, or is produced within a specific site (e.g., tumor) at concentrations that are higher than that in normal tissues. Alternatively, the enzyme is conjugated to a targeting moiety such as an antibody or a receptor-binding molecule.